These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31956008)

  • 1. Corrigendum to "Nucleosome binding peptide presents laudable biophysical and in vivo effects" [Biomed. Pharmacother. 121 (2020) 109678].
    Teles K; Fernandes V; Silva I; Leite M; Grisolia C; Lobbia VR; van Ingen H; Honorato R; Lopes-de-Oliveira P; Treptow W; Santos G
    Biomed Pharmacother; 2020 Mar; 123():109805. PubMed ID: 31956008
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "Chondroprotective effects of aqueous extract of Anthriscus sylvestris leaves on osteoarthritis in vitro and in vivo through MAPKs and NF-κB signaling inhibition" [Biomed. Pharmacother. 103 (2018) 1202-1211].
    Lee SA; Moon SM; Han SH; Hwang EJ; Park BR; Kim JS; Kim DK; Kim CS
    Biomed Pharmacother; 2020 Jul; 127():110190. PubMed ID: 32423657
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR/AMPK signaling pathway in vivo" [Biomed. Pharmacother. 97 (2018) 481-488].
    Zheng L; Yin L; Xu L; Qi Y; Li H; Youwei X; Han X; Liu K; Peng J
    Biomed Pharmacother; 2019 Dec; 120():109448. PubMed ID: 31615697
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo" [Biomed. Pharmacother. 116 (2019) 109032].
    Weng MC; Li MH; Chung JG; Liu YC; Jeng-Yuan W; Hsu FT; Wang HE
    Biomed Pharmacother; 2019 Oct; 118():109209. PubMed ID: 31324388
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Ginsenoside Rd contributes the attenuation of cardiac hypertrophy in vivo and in vitro" [Biomed. Pharmacother. 109 (2019) 1016-1023].
    Zhang N; An X; Lang P; Wang F; Xie Y
    Biomed Pharmacother; 2020 Oct; 130():110720. PubMed ID: 34321161
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Pro-apoptotic effects of Amblyomin-X in murine renal cell carcinoma "in vitro" [Biomed. Pharmacother. 66 (2012) 64-69].
    Akagi EM; de Sá Júnior PL; Simons SM; Bellini MH; Barreto SA; Chudzinski-Tavassi AM
    Biomed Pharmacother; 2019 Oct; 118():109108. PubMed ID: 31235339
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Exosomes: An emerging factor in atherosclerosis" [Biomed. Pharmacother. 115 (2019) 108951].
    Wang Y; Xie Y; Zhang A; Wang M; Fang Z; Zhang J
    Biomed Pharmacother; 2019 Oct; 118():109119. PubMed ID: 31230947
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Luteolin, a flavonoid, as an anticancer agent: A review" [Biomed. Pharmacother. 112 (2019) 108612].
    Imran M; Rauf A; Abu-Izneid T; Nadeem M; Shariati MA; Khan IA; Imran A; Erdogan Orhan I; Rizwan M; Atif M; Aslam Gondal T; Mubarak MS
    Biomed Pharmacother; 2019 Aug; 116():109084. PubMed ID: 31178263
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "double sword role of EZH2 in leukemia" [Biomed. Pharmacother. 98 (2018) 626-635].
    Safaei S; Baradaran B; Hagh MF; Alivand MR; Talebi M; Gharibi T; Solali S
    Biomed Pharmacother; 2018 May; 101():786. PubMed ID: 29525673
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Comparative study of therapeutic response to baclofen vs tolperisone in spasticity" [Biomed. Pharmacother. 87 (2017) 628-635].
    Agarwal S; Patel T; Shah N; Patel BM
    Biomed Pharmacother; 2017 Aug; 92():1140. PubMed ID: 28623068
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Protective effects of higenamine combined with [6]-gingerol against doxorubicin-induced mitochondrial dysfunction and toxicity in H9c2 cells and potential mechanisms" [Biomed. Pharmacother. 115 (2019) 108881].
    Wen J; Wang J; Li P; Wang R; Wang J; Zhou X; Zhang L; Li H; Wei S; Cai H; Zhao Y
    Biomed Pharmacother; 2019 Jul; 115():108936. PubMed ID: 31101386
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Herb-drug interaction: A case study of effects and involved mechanisms of cisplatin on the pharmacokinetics of ginsenoside Rb1 in tumor-bearing mice" [Biomed. Pharmacother. 110 (2019) 95-104].
    Zhou J; Wu J; Wu CY; Long F; Shen H; Zhang W; Li SL
    Biomed Pharmacother; 2019 Jun; 114():108827. PubMed ID: 30954310
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Chrysin-nanoencapsulated PLGA-PEG for macrophage repolarization: Possible application in tissue regeneration" [Biomed. Pharmacother. 105 (2018) 773-780].
    Firouzi-Amandi A; Dadashpour M; Nouri M; Zarghami N; Serati-Nouri H; Jafari-Gharabaghlou D; Karzar BH; Mellatyar H; Aghebati-Maleki L; Babaloo Z; Pilehvar-Soltanahmadi Y
    Biomed Pharmacother; 2019 Oct; 118():109145. PubMed ID: 31272743
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Study on the efficacy and mechanism of triptolide on treating TNF transgenic mice with rheumatoid arthritis" [Biomed. Pharmacother. 106 (2018) 813-820].
    Wang S; Zuo S; Liu Z; Ji X; Yao Z; Wang X
    Biomed Pharmacother; 2019 Mar; 111():1509. PubMed ID: 30413297
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review" [Biomed. Pharmacother. 92 (2017) 681-689].
    Anjum K; Shagufta BI; Abbas SQ; Patel S; Khan I; Shah SAA; Akhter N; Shams-Ul-Hassan S
    Biomed Pharmacother; 2018 May; 101():820. PubMed ID: 29525678
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Dexmedetomidine relieves formaldehyde-induced pain in rats through both α2 adrenoceptor and imidazoline receptor" [Biomed. Pharmacother. 90 (2017) 914-920].
    Zhang H; Yan X; Wang DG; Leng YF; Wan ZH; Liu YQ; Zhang Y
    Biomed Pharmacother; 2017 Dec; 96():1569. PubMed ID: 29153378
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Evaluation of antiviral effect and toxicity of total flavonoids extracted from Robinia pseudoacacia cv. idaho" [Biomed. Pharmacother. 118 (2019) 109335].
    Guo H; Wan X; Niu F; Sun J; Shi C; Ye JM; Zhou C
    Biomed Pharmacother; 2020 Mar; 123():109809. PubMed ID: 31917053
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC" [Biomed. Pharmacother. 110 (2019) 656-666].
    Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
    Biomed Pharmacother; 2019 Apr; 112():108755. PubMed ID: 30871752
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to 'Rutaecarpine administration inhibits cancer cell growth in allogenic TRAMP-C1 prostate cancer mice correlating with immune balance in vivo' [Biomed. Pharmacother. 139 (2021) 111648].
    Yeh TH; Lin JY
    Biomed Pharmacother; 2021 Sep; 141():111751. PubMed ID: 34144859
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Dysbiosis of gut microbiota is associated with gastric carcinogenesis in rats" [Biomed Pharmacother. 126 (2020) 110036].
    Yu C; Su Z; Li Y; Li Y; Liu K; Chu F; Liu T; Chen R; Ding X
    Biomed Pharmacother; 2020 Aug; 128():110269. PubMed ID: 32482443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.